KBIO COMPANY Inc. (KOSDAQ:038530)
South Korea
· Delayed Price · Currency is KRW 251.00
+1.00 (0.40%)
At close: Dec 5, 2025
KBIO COMPANY Revenue
KBIO COMPANY had revenue of 17.58B KRW in the quarter ending September 30, 2025, with 6.42% growth. This brings the company's revenue in the last twelve months to 83.85B, up 43.78% year-over-year. In the year 2024, KBIO COMPANY had annual revenue of 76.51B with 180.02% growth.
Revenue (ttm)
83.85B
Revenue Growth
+43.78%
P/S Ratio
0.35
Revenue / Employee
2.15B
Employees
39
Market Cap
28.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 76.51B | 49.19B | 180.02% |
| Dec 31, 2023 | 27.32B | -3.80B | -12.22% |
| Dec 31, 2022 | 31.13B | 22.41B | 256.90% |
| Dec 31, 2021 | 8.72B | 3.01B | 52.80% |
| Dec 31, 2018 | 5.71B | 676.84M | 13.45% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| Kia Corporation | 113.20T |
| HD Hyundai Heavy Industries | 16.39T |